Discussions
Discussions
Ksmiles123 Check-In 12/08/2025
Hello! Below is a part of the recent presentation done by Dr. Doreen Adrizzio , from the recent North American BNTM conference. This summary of the conference highlights was sponsored by Running on Air and NTM Information and Research.
DPP-1 Inhibitors
There is a lot of interest in the new drugs that are targeting inflammation in Bronchiectasis, from the first FDA approved treatment to on going drug studies. Below are some links and information:
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Webinar - Dipeptidyl Peptidase 1 (DPP-1) Inhibitors for Bronchiectasis - Overview and Q &A
Starting to Recruit: The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
It is not our intention to serve as a substitute for medical advice and any content posted should not be used for medical advice, diagnosis or treatment. We make every effort to support our members, our medical professionals cannot and will not provide a diagnosis or suggest a specific medication; those decisions should be left to your personal medical team. While we encourage individuals to share their personal experiences with COPD, please consult a physician before making changes to your own COPD management plan.
Community posts are monitored by the 360social Community Manager, as well as staff respiratory therapists, educators, and other medical professionals.